Security key
77313F106
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 92,048,164
- Share change
- +4,173,178
- Total reported value
- $2,479,705,726
- Put/Call ratio
- 46%
- Price per share
- $26.94
- Number of holders
- 183
- Value change
- +$111,013,838
- Number of buys
- 86
- Number of sells
- 87
Report period
Q1 2024
Institutions
183
Top holders
10
RCKT full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
ROCKET PHARMACEUTICALS, INC. SEC filings
ROCKET PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 77313F106
Recent filing periods:
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.5%
|
8,197,546
|
$245,680,453 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
5,930,178
|
$177,727,435 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
5,447,565
|
$163,263,523 | — | 31 Dec 2023 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.7%
|
4,034,068
|
$120,901,018 | — | 31 Dec 2023 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
3.6%
|
3,941,859
|
$118,137,514 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
3,231,411
|
$96,845,388 | — | 31 Dec 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.4%
|
2,629,074
|
$78,794,000 | — | 31 Dec 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
1.6%
|
1,719,103
|
$51,521,517 | — | 31 Dec 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
1,707,398
|
$51,170,718 | — | 31 Dec 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.4%
|
1,523,013
|
$45,644,700 | — | 31 Dec 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,466,051
|
$43,937,548 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,457,250
|
$43,679,432 | — | 31 Dec 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
1,347,163
|
$40,374,475 | — | 31 Dec 2023 | |
| Logos Global Management LP |
13F
|
Company |
1.2%
|
1,275,000
|
$38,211,750 | — | 31 Dec 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.2%
|
1,260,900
|
$37,789,173 | — | 31 Dec 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.98%
|
1,072,910
|
$32,155,113 | — | 31 Dec 2023 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.98%
|
1,069,715
|
$32,059,359 | — | 31 Dec 2023 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.96%
|
1,052,501
|
$31,543,455 | — | 31 Dec 2023 | |
| Novo Holdings A/S |
13F
|
Company |
0.96%
|
1,050,000
|
$31,468,500 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.96%
|
1,047,941
|
$31,408,737 | — | 31 Dec 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.87%
|
949,905
|
$28,425,926 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.73%
|
793,738
|
$23,788,327 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.68%
|
748,340
|
$22,427,750 | — | 31 Dec 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.64%
|
702,625
|
$21,057,671 | — | 31 Dec 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.59%
|
648,946
|
$19,448,927 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
628,705
|
$18,842,289 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.56%
|
611,973
|
$18,340,831 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
594,665
|
$17,822,097 | — | 31 Dec 2023 | |
| COMERICA BANK |
13F
|
Company |
0.51%
|
558,025
|
$16,724,009 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
0.48%
|
529,496
|
$15,868,992 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
525,452
|
$15,747,796 | — | 31 Dec 2023 | |
| M28 Capital Management LP |
13F
|
Company |
0.48%
|
523,280
|
$15,682,702 | — | 31 Dec 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
490,732
|
$14,707,238 | — | 31 Dec 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.41%
|
450,000
|
$13,486,500 | — | 31 Dec 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.33%
|
366,015
|
$10,969,470 | — | 31 Dec 2023 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.28%
|
306,500
|
$9,185,805 | — | 31 Dec 2023 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
296,013
|
$9,146,802 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.23%
|
254,916
|
$7,639,833 | — | 31 Dec 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.23%
|
250,000
|
$7,492,500 | — | 31 Dec 2023 | |
| NORGES BANK |
13F
|
Company |
0.22%
|
243,351
|
$7,293,229 | — | 31 Dec 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.22%
|
239,726
|
$7,184,588 | — | 31 Dec 2023 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.21%
|
233,050
|
$6,874,975 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
232,490
|
$6,967,724 | — | 31 Dec 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.19%
|
208,505
|
$6,248,895 | — | 31 Dec 2023 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.18%
|
193,350
|
$5,794,700 | — | 31 Dec 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.17%
|
190,783
|
$5,717,767 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
177,535
|
$5,320,723 | — | 31 Dec 2023 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.16%
|
172,474
|
$5,169,045 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
163,419
|
$4,897,668 | — | 31 Dec 2023 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.14%
|
156,000
|
$4,675,320 | — | 31 Dec 2023 |
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q1 2024
As of 31 Mar 2024,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,048,164 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC.
This page lists
183
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
192
Q1 2024 holders
183
Holder diff
-9
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.